Educational | Monitoring & Feedback | Formulary* | Collaborative Care Involving Pharmacists | Disease Management† | TOTAL | |
---|---|---|---|---|---|---|
All studies | 20 | 22 | 66 | 15 | 41 | 164 |
Methodologically acceptable studies | 7 | 16 | 15 | 5 | 8 | 51 |
RCT | 5 | 10 | 2 | 3 | 7 | 27 |
Interrupted time series | 0 | 5 | 5 | 0 | 0 | 10 |
Pre/post studies with comparison | 2 | 1 | 8 | 2 | 1 | 14 |
Interventions in methodologically acceptable studies‡ | 17 | 18 | 21 | 5 | 8 | 69 |